View of Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triplenegative breast cancer in a real-world scenario: the Neo-Real/GBECAM-0123 study

Return to Article Details Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triplenegative breast cancer in a real-world scenario: the Neo-Real/GBECAM-0123 study Download Download PDF